Latest News From BioPharmaChem
06 December, 2011
The PharmaChem skillnet launched today their newly developed GXP course.The course was developed internally and candidates will be taken through an intensive 5 day course dealing with the fundamentals required to work in the pharmaceutical industry.
07 December, 2011
Bayer and Johnson & Johnson ($JNJ) snagged the crucial stroke-prevention indication for their new clot-fighter Xarelto. The FDA approval isn't without its caveats, however. FDA may have granted the new use despite objections from staffers, who had questioned the usefulness of a key study, but the agency didn't give Xarelto a snag-free label
14 December, 2011
Johnson & Johnson is releasing new batches of Doxil, a cancer drug that has been in short supply recently as a result of problems at contract manufacturer Ben Venue Laboratories, a unit of Boehringer Ingelheim.